Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
Open, multicentre, phase II trial of atezolizumab with concurrent normofractionated
radiotherapy in patients with localized muscle-invasive bladder cancer treated with a
selective multimodality bladder conservative approach.